Live Breaking News & Updates on Johnson Innovative Medicine

Stay updated with breaking news from Johnson innovative medicine. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

J&J scratches AD itch by acquiring experimental eczema antibody for $1.25B

J&J will pick up Yellow Jersey Therapeutics, a wholly-owned subsidiary of Numab Therapeutics, for $1.25 billion to acquire all assets related to NM26. ....

David Urech , David Lee , Ambrx Biopharma , Drug Administration , Johnson Innovative Medicine , Yellow Jersey Therapeutics , Numab Therapeutics ,